What are your top takeaways in Head & Neck Cancers from ASTRO 2024?

Here are my impressions from 3 interesting presentations related to head and neck cancer:

1. S2-S3, Yom et al., Interim futility results of NRG-HN005 a randomized phase II/III non-inferiority trial for non-smoking p16+ oropharyngeal ca. The study tested non-inferiority regarding DFS of two de-escalate...